Proxy Votes Now

Home › Funds › Saratoga Health & Biotechnology Portfolio

Saratoga Health & Biotechnology Portfolio (SBHIX) proxy voting record 2025-2026

Fund family: SARATOGA ADVANTAGE TRUST · Filed by SARATOGA ADVANTAGE TRUST (CIK 924628) · SEC series S000010884

Share classes and tickers: SBHIX (C000030151), SHPAX (C000030154), SHPCX (C000030153)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 302 with, 0 against, 0 abstentions (not counted as with management); 1 items carried no recommendation. Shareholder proposals: 0 FOR, 0 AGAINST, 0 abstained, by the filing’s own vote-source field.

No item-level comparison with other SARATOGA ADVANTAGE TRUST funds is possible: no ballot item of this fund was voted by at least three other funds of the family with a clear majority.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 90.7% of this fund’s 302 such votes could be given a sector; the other 28 (9.3%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care27400.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections2270
Say-on-Pay260
Audit-related240
Compensation90
Capital Structure80
Corporate Governance80
Shareholder Rights and Defenses30

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
McKesson CorporationJuly 30, 2025$1M140
Cardinal Health, Inc.November 5, 2025$973,390140
Amgen Inc.May 19, 2026$809,985140
United Therapeutics CorporationJune 26, 2026$681,941150
Regeneron Pharmaceuticals, Inc.June 12, 2026$638,10870
Cencora, Inc.March 5, 2026$600,966130
Exelixis, Inc.May 26, 2026$533,110140
Johnson & JohnsonApril 23, 2026$514,769140

Search this fund’s votes by company

305 ballot items at 25 meetings in 2025-2026. Download all votes (CSV)

About this fund’s record

In the 2025-2026 proxy season, Saratoga Health & Biotechnology Portfolio (SBHIX) voted at 25 shareholder meetings of 25 companies, on 305 ballot items in all. Where management made a recommendation, the fund followed it on 100.0% of the items and voted against it 0 times.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.